Current situation on biomarker validation in Japan

Bioanalysis. 2018 Jun 1;10(12):901-903. doi: 10.4155/bio-2017-0244. Epub 2018 Jun 20.

Authors

Yoshiro Saito¹, Noriko Katori², Yoshiaki Ohtsu³

Affiliations

¹ Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki, Japan.
² Division of Drugs, National Institute of Health Sciences, Kawasaki, Japan.
³ Analysis & Pharmacokinetics Research Laboratories, Astellas Pharma, Inc., Tsukuba, Japan.

PMID: 29923737
DOI: 10.4155/bio-2017-0244

No abstract available

Keywords: Japanese situation; biomarker assay validation; guideline.

Publication types

Editorial

MeSH terms

Biomarkers / analysis*
Chemistry Techniques, Analytical*
Humans
Japan
Reproducibility of Results
Validation Studies as Topic

Substances

Biomarkers